These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

882 related items for PubMed ID: 21946205

  • 21. Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation.
    Urbano-Ispizua A, Brunet S, Solano C, Moraleda JM, Rovira M, Zuazu J, de La Rubia J, Bargay J, Caballero D, Díez-Martín JL, Ojeda E, Pérez de Oteiza JP, Ferrá C, Espigado I, Alegre A, de La Serna J, Torres P, Riu C, Odriozola J, Rozman C, Sierra J, García-Conde J, Montserrat E, Spanish Group of Allo-PBT.
    Bone Marrow Transplant; 2001 Aug; 28(4):349-54. PubMed ID: 11571506
    [Abstract] [Full Text] [Related]

  • 22. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
    De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R.
    Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
    [Abstract] [Full Text] [Related]

  • 23. [The significance of serial monitoring of bcr-abl transcripts levels after allogeneic hematopoietic stem cell transplantation in screening chronic myeloid leukemia patients with low relapse].
    Xu LP, Liu KY, Huang XJ, Liu DH, Han W, Chen YH, Wang Y, Liu YR, Qin YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):522-5. PubMed ID: 19112914
    [Abstract] [Full Text] [Related]

  • 24. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y, Feng SZ, Wang M, Wei JL, Qin TJ, Zhou Z, Zhai WJ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
    [Abstract] [Full Text] [Related]

  • 25. [A comparison of clinical outcomes between unrelated donor and HLA-haploidentical donor hematopoietic stem cell transplantation].
    Chen F, Wu DP, Sun AN, Ma X, Tang XW, Qiu HY, Miao M, Fu ZZ, Jin ZM, Wang Y, Wu XJ, Chen SN, He GS, Wang XL, Xue SL, Zhao Y, Chang WR.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):83-6. PubMed ID: 18681306
    [Abstract] [Full Text] [Related]

  • 26. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
    Wang Y, Liu KY, Xu LP, Liu DH, Chen H, Han W, Chen YH, Shi HX, Zhang YC, Wang JZ, Zhang XU, Chen Y, Huang XJ, Lu DP.
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
    [Abstract] [Full Text] [Related]

  • 27. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
    Liu QF, Sun J, Xu D, Zhang Y, Fan ZP, Wei YQ, Meng FY, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
    [Abstract] [Full Text] [Related]

  • 28. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 29. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission.
    Fagioli F, Zecca M, Locatelli F, Lanino E, Uderzo C, Di Bartolomeo P, Berger M, Favre C, Rondelli R, Pession A, Messina C, AIEOP-HSCT group.
    J Pediatr Hematol Oncol; 2008 Aug; 30(8):575-83. PubMed ID: 18799933
    [Abstract] [Full Text] [Related]

  • 31. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

  • 32. [Exploration of acute graft versus host disease and its risk factors after allo-hematopoietic stem cell transplantation].
    Chen YH, Huang XJ, Guo NL, Ren HY, Zhang YC, Xu LP, Gao ZY, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):61-3. PubMed ID: 12697096
    [Abstract] [Full Text] [Related]

  • 33. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up].
    Bao YS, Jiang EL, Wang M, Wang H, Huang Y, Wei JL, Yang DL, Feng SZ, Qiu LG, Han MZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 36. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
    Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F.
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis.
    Wu Q, Chen H, Fang J, Xie W, Hong M, Xia L.
    Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312
    [Abstract] [Full Text] [Related]

  • 39. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ, Xu LP, Ren HY, Zhang YC, Guo NL, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):766-9. PubMed ID: 12899755
    [Abstract] [Full Text] [Related]

  • 40. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y, Lu DP, Liu KY, Dong LJ, Ren HY, Huang XJ, Chen H, Liu DH, Jiang Q, Chen YH, Xu LP, Zhang YC, Lu J, Gao ZY.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb 10; 26(2):74-7. PubMed ID: 15921621
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.